April 1, 2013
Public relations and compliance officers at drug makers are stumbling over an ambiguous communications provision in the Japan Pharmaceutical Manufacturers Association’s (JPMA) code of practice (COP), which will come into effect on April 1. Although the COP urges JPMA member...read more